Pharmaceutical cleanroom teams are increasingly treating design and validation as mission-critical business levers rather than regulatory checkboxes. Industry guidance and benchmarking from ISPE show ...
The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease, ...
Track Orient Technologies share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...
Saelig Company, Inc. has introduced RadGreen RadSys RF Monitors which provide continuous RF radiation sensing and alerts across various bandwidths in indoor and outdoor environments.
Insilico Medicine has shown that generative AI can dramatically accelerate drug discovery, but its bigger challenge is ...
QT9 Software has updated its ERP software to help regulated manufacturers handle growing operational complexity without adding overhead.
It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...
StockStory.org on MSN
1 momentum stock worth your attention and 2 facing challenges
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically ...
Among the new additions are a new supplemental guideline on computer software assurance for artificial intelligence (AI)-based systems in drug manufacturing and clinical investigations, as well as new ...
Good morning, and thank you for joining us on day 3 of the 47th Annual Goldman Sachs Global Healthcare Conference. I'm Paul Choi, and I cover the mid-cap biotech sector here at the firm. It's our ...
All right. Let's kick off the next session. Good afternoon, everyone. It is my pleasure to be hosting Olema Oncology and Sean Bohen, CEO of the company. Sean, welcome. Glad to be hosting you for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results